Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Sep 08, 2021 9:43am
207 Views
Post# 33824220

RE:RE:RE:RE:RE:RE:RE:RE:THTX presenting to HC Wainwright conf.

RE:RE:RE:RE:RE:RE:RE:RE:THTX presenting to HC Wainwright conf.When TH is preseenting at the first 4, we will be feeling pretty good about the stock price. Until TH has some very intriguing cancer data, however, they will likely only get opportunities at the lower impact conferences like Wainwright and Cantor. 

Hopefully, the cancer phase 1a data will start the process of getting TH into those more impactful investor conferences.

qwerty22 wrote:

Somebody tweeted this list of upcoming biotech conferences. 

9/7 - Goldman London
9/8-10 Citi
9/9-15 Morgan Stanley
9/9-10 Wells Fargo
9/13-15 HCW
9/14-15 Baird
9/16-21
#ESMO21
9/20-23 Oppenheimer
9/22-23 - SVB CybeRx
9/27-30 Cantor


That's a lot of pitches! 

 

SPCEO1 wrote: Apparently, there are going to be 850 companies participating in the conference. I am not going to do the math, but clearly, some of those presentations will need to be pre-recorded late this week to be made available during the 9/13-15 conference time. 
 

 

scarlet1967 wrote: The conference starts on 13 so I am
not sure how it can be prerecorded 7 am on the first day??
Global Investment Conference being held virtually September 13 – 15, 2021.    

Wino115 wrote: PR says it will be available "on demand" as of 7am that day. Given it's virtual, it sounds like it may be a pre-recorded pitch and Q&A by Paul.  Most likely pre-recorded sometime earlier, so won't conflict with KOL event that afternoon. 

They are small and were one of the brokers active with a lot of the oncology names when I looked at the NASH and oncology analysts for a slew of companies. Very fundamental firm, but like SPCeo says, on the small side and not a major market opinion leader on biotech. Every little bit helps though.


Bucknelly21 wrote:
scarlet1967 wrote: Nothing on Stocktwits or Yahoo finance, if they want to save money that's not the place!
I am not sure why two events on the same day? Unless there is a valid reason it would be better to have them on different days.

Wouldn't need to save money if they had proper value 

 

 

 




<< Previous
Bullboard Posts
Next >>